Pulmonx Gross Profit 2019-2025 | LUNG

Pulmonx gross profit from 2019 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Pulmonx Annual Gross Profit
(Millions of US $)
2024 $62
2023 $51
2022 $40
2021 $36
2020 $21
2019 $22
2018 $12
Pulmonx Quarterly Gross Profit
(Millions of US $)
2025-09-30 $16
2025-06-30 $17
2025-03-31 $16
2024-12-31 $18
2024-09-30 $15
2024-06-30 $15
2024-03-31 $14
2023-12-31 $14
2023-09-30 $13
2023-06-30 $13
2023-03-31 $11
2022-12-31 $11
2022-09-30 $10
2022-06-30 $10
2022-03-31 $8
2021-12-31 $10
2021-09-30 $10
2021-06-30 $9
2021-03-31 $7
2020-12-31 $7
2020-09-30 $7
2020-06-30 $1
2020-03-31 $6
2019-12-31
2019-09-30 $6
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.061B $0.084B
Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $48.084B 58.67
Tempus AI (TEM) United States $11.897B 0.00
Doximity (DOCS) United States $9.342B 38.47
Hims & Hers Health (HIMS) United States $8.418B 68.48
IRhythm Technologies (IRTC) United States $5.504B 0.00
Hinge Health (HNGE) United States $3.224B 0.00
Privia Health (PRVA) United States $2.884B 180.38
Inspire Medical Systems (INSP) United States $2.509B 41.51
Heartflow (HTFL) United States $2.383B 0.00
10x Genomics (TXG) United States $1.978B 0.00
Enovis (ENOV) United States $1.715B 9.01
Omnicell (OMCL) United States $1.576B 32.22
Azenta (AZTA) United States $1.364B 59.50
Phreesia (PHR) United States $1.304B 0.00
Schrodinger (SDGR) United States $1.299B 0.00
Clover Health Investments (CLOV) United States $1.276B 0.00
Fulgent Genetics (FLGT) United States $0.900B 0.00
Claritev (CTEV) United States $0.715B 0.00
Talkspace (TALK) United States $0.538B 108.33
Butterfly Network (BFLY) United States $0.536B 0.00
Veradigm (MDRX) United States $0.523B 0.00
Standard BioTools (LAB) United States $0.477B 0.00
Evolent Health (EVH) United States $0.466B 0.00
Carlsmed (CARL) United States $0.349B 0.00
Zepp Health (ZEPP) Netherlands $0.348B 0.00
TruBridge (TBRG) United States $0.306B 14.05
SOPHiA GENETICS SA (SOPH) Switzerland $0.291B 0.00
CapsoVision (CV) United States $0.239B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.212B 0.00
KORU Medical Systems (KRMD) United States $0.200B 0.00
MDxHealth SA (MDXH) Belgium $0.172B 0.00
Nyxoah SA (NYXH) Belgium $0.170B 0.00
Health Catalyst (HCAT) United States $0.160B 0.00
CareCloud (CCLD) United States $0.133B 7.28
EUDA Health Holdings (EUDA) Singapore $0.110B 0.00
Outset Medical (OM) United States $0.085B 0.00
American Well (AMWL) United States $0.066B 0.00
NetraMark Holdings (AINMF) Canada $0.066B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.049B 0.00
111 (YI) China $0.035B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Precipio (PRPO) United States $0.031B 0.00
Predictive Oncology (POAI) United States $0.027B 0.00
Lunai Bioworks (LNAI) United States $0.025B 0.00
Zhongchao (ZCMD) China $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.012B 0.00
Bullfrog AI Holdings (BFRG) United States $0.010B 0.00
Movano (MOVE) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.002B 0.00
MSP Recovery (MSPR) United States $0.001B 0.00